Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuroscience ; 492: 92-107, 2022 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-35367290

RESUMO

Amantadine and clozapine have proved to reduce abnormal involuntary movements (AIMs) in preclinical and clinical studies of L-DOPA-Induced Dyskinesias (LID). Even though both drugs decrease AIMs, they may have different action mechanisms by using different receptors and signaling profiles. Here we asked whether there are differences in how they modulate neuronal activity of multiple striatal neurons within the striatal microcircuit at histological level during the dose-peak of L-DOPA in ex-vivo brain slices obtained from dyskinetic mice. To answer this question, we used calcium imaging to record the activity of dozens of neurons of the dorsolateral striatum before and after drugs administration in vitro. We also developed an analysis framework to extract encoding insights from calcium imaging data by quantifying neuronal activity, identifying neuronal ensembles by linking neurons that coactivate using hierarchical cluster analysis and extracting network parameters using Graph Theory. The results show that while both drugs reduce LIDs scores behaviorally in a similar way, they have several different and specific actions on modulating the dyskinetic striatal microcircuit. The extracted features were highly accurate in separating amantadine and clozapine effects by means of principal components analysis (PCA) and support vector machine (SVM) algorithms. These results predict possible synergistic actions of amantadine and clozapine on the dyskinetic striatal microcircuit establishing a framework for a bioassay to test novel antidyskinetic drugs or treatments in vitro.


Assuntos
Clozapina , Discinesia Induzida por Medicamentos , Amantadina/farmacologia , Animais , Antiparkinsonianos/farmacologia , Cálcio , Clozapina/farmacologia , Corpo Estriado , Modelos Animais de Doenças , Discinesia Induzida por Medicamentos/tratamento farmacológico , Discinesia Induzida por Medicamentos/patologia , Levodopa/toxicidade , Camundongos , Neurônios , Oxidopamina/farmacologia
2.
Neurotox Res ; 34(4): 860-869, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29302849

RESUMO

The dose-dependent effects of alcohol, where the initial euphoric and stimulant effects initiated by the exposure to low ethanol levels can quickly lead to a deadly consequence are well established. Thus, high blood alcohol concentration (BAC), as seen in alcoholics, can cause significant damage to various organs. At low concentrations (e.g., 10 mg% or lower), however, beneficial effects of alcohol, particularly on cardiovascular function have been reported. Although, the latter assertion has been challenged by recent epidemiological studies, protective effects of low alcohol concentrations in vitro and in vivo relevant to the central nervous system (CNS) is well documented. In this review, the mechanism(s) leading to the detrimental effects of high BAC, as well as the beneficial effects of low BAC will be discussed. In addition, gender consideration is touched upon. Although further investigation is clearly warranted, it may be concluded that at least some of the beneficial outcomes of low BAC, including possible neuroprotection and antidepressant-like effects, may be due to elevation of the neurotropic factors and reduction of inflammatory mediators, whereas detrimental outcomes associated with high BAC, including neurotoxicity and depressive-like behavior may be due to reduction in neurotropic factors and elevation of inflammatory mediators. Furthermore, new research strategies are suggested.


Assuntos
Depressores do Sistema Nervoso Central/toxicidade , Depressores do Sistema Nervoso Central/uso terapêutico , Etanol/toxicidade , Etanol/uso terapêutico , Consumo de Bebidas Alcoólicas/epidemiologia , Animais , Concentração Alcoólica no Sangue , Humanos , Neuroproteção/efeitos dos fármacos
3.
Neuroscience ; 387: 123-134, 2018 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-28890053

RESUMO

The present study evaluates the possible antinociceptive effect of chromosphere transplants in rats injected with 6-hydroxydopamine (6-OHDA), a model of Parkinson's disease. Male adult Wistar rats received 40µg/0.5µl of 6-OHDA or 0.5µl of vehicle into the left substantia nigra (SNc). Rats were evaluated for mechanical allodynia, cold allodynia, thermal hyperalgesia and formalin. Rats with altered nociceptive threshold were transplanted with chromospheres. After transplant, rats were evaluated every week. Our results confirm that 6-OHDA injection into rat's SNc reduces mechanical, thermal, and chemical thresholds. Interestingly, chromospheres' transplant reverted 6-OHDA-induced allodynia and hyperalgesia. The antinociceptive effect induced by chromospheres was dopamine D2- and opioid-receptor dependent since sulpiride or naltrexone reverted its effect.


Assuntos
Nociceptividade/efeitos dos fármacos , Nociceptividade/fisiologia , Transtornos Parkinsonianos/fisiopatologia , Animais , Células Cultivadas , Masculino , Microinjeções , Naltrexona/farmacologia , Oxidopamina/efeitos adversos , Medição da Dor , Transtornos Parkinsonianos/induzido quimicamente , Ratos , Substância Negra/efeitos dos fármacos , Sulpirida/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...